Viewing Study NCT06054906


Ignite Creation Date: 2025-12-26 @ 4:04 PM
Ignite Modification Date: 2026-01-22 @ 8:45 AM
Study NCT ID: NCT06054906
Status: RECRUITING
Last Update Posted: 2024-12-30
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer
Sponsor: Huashan Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
Keywords: